Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **nematode GABA-A receptor** is a ligand-gated chloride ion channel found in nematode nervous systems, especially studied in *Caenorhabditis elegans* and various parasitic nematodes[2][7]. It is encoded by the *unc-49* gene, which produces multiple subunits (UNC-49A, UNC-49B, UNC-49C) via alternative splicing[2][3]. The physiologically functional receptor at the neuromuscular junction is primarily a heteromer of UNC-49B and UNC-49C, where UNC-49B serves as the principal GABA-responsive and synaptic localization unit, while UNC-49C modulates desensitization kinetics and shapes inhibitory postsynaptic currents[2][3]. This receptor is central to inhibitory neurotransmission, enabling muscle relaxation during locomotion by conducting chloride ions in response to GABA released from inhibitory neurons[3][7]. It differs from vertebrate GABA-A receptors in its subunit composition and pharmacology, providing opportunities for selective anthelmintic drug development. Several anthelmintics (notably ivermectin) target nematode GABA-A receptors, often leading to paralysis and death of the worm[7][3]. Resistance to such drugs is a major concern in parasitic nematode infections affecting animals and humans.
Positive allosteric modulation (ivermectin enhances channel activity); Antagonism (picrotoxin blocks the chloride channel); Agonism (muscimol acts as a full agonist); Inhibition/desensitization modulation (pregnenolone sulfate acts as an antagonist)[2][3][7]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor, nematode type (UNC-49, GABA-A receptor, C. elegans) (Nematode GABA-A receptor).